Audio Journal of Oncology – June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of George Canellos

George Canellos

Carmela Pepe

John Goldman

Roy Herbst

Sandra Horning

George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the ASCO annual meeting in Atlanta.

– Elderly patients with non-small cell lung cancer can benefit from chemotherapy after surgery, and do not experience increased toxicity when compared to younger patients – that’s according toCarmela Pepeof the Princess Margaret Hospital in Toronto (abstract 7009)
– the Oncology Drugs Advisory Committee has concluded that the drug dasatinib should be recommended for the treatment of chronic myeloid leukaemia. Breaking the news at the Atlanta meeting wasJohn Goldmanof Imperial College London, and the National Heart Lung and Blood Institute, NIH, Bethesda
–Roy Herbstfrom the MD Anderson Cancer Center in Houston tells the Audio Journal about some of the most exciting announcements to be made at the 2006 ASCO conference, including progress in multiple myeloma and targeted therapy in renal cancer
– the outgoing president of ASCO,Sandra Horning, of Stanford University, explains how ASCO has focussed on cancer survivorship over the last year – and how cancer survivors can expect to receive more support in the future.